Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Linagliptin impurity 2, also known as Linagliptin acetamide, is a structural impurity associated with Linagliptin, an oral antihyperglycemic agent. This compound is primarily utilized in quality control and analytical applications to ensure the purity of Linagliptin formulations. Its identification and quantification are vital for regulatory compliance and to assess the compound's stability and safety profiles in pharmaceutical development. -
Drug Impurity
Ibuprofen impurity 3, also known as Ibuprofen EP impurity H, is a chemical impurity associated with the pharmaceutical compound Ibuprofen. This reagent is crucial for quality control and compliance testing in the development and manufacturing of Ibuprofen formulations. It is utilized in research to evaluate the purity and safety profiles of Ibuprofen, ensuring adherence to regulatory standards in pharmaceutical analysis. -
Drug Impurity
Glipizide impurity 3, also known as Glipizide impurity D, is a chemical impurity associated with Glipizide, a medication primarily used to manage type 2 diabetes. Characterizing this impurity is crucial for ensuring the quality and safety of pharmaceutical formulations. Its analysis plays a vital role in regulatory compliance and can provide insights into the stability and efficacy of Glipizide-containing products. -
Drug Impurity
Tenofovir impurity 8 fumarate is a known impurity associated with Tenofovir fumarate, an antiviral agent primarily targeting HIV. This compound serves as a critical reference standard in analytical chemistry and quality control for pharmaceutical formulation and development, ensuring the purity and efficacy of Tenofovir-based medications. Its identification and quantification are essential for compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Lincomycin impurity 2, also known as Methyl 1-thiolincosaminide, serves as a drug impurity associated with Lincomycin. This compound can play a significant role in the assessment of pharmaceutical formulations, particularly in quality control studies and stability testing. Researchers investigating the pharmacokinetics and metabolic pathways of lincomycin may employ this impurity for comprehensive analytical evaluations. -
Drug Impurity
Estradiol Valerate impurity 3 is a chemical impurity associated with Estradiol Valerate. This compound is significant for analytical purposes in ensuring the quality and purity of estradiol-based formulations. It plays a critical role in the study of pharmacokinetics and drug metabolism, aiding researchers in developing safer and more effective therapeutic options. -
Drug Intermediate
(R)-(4-Bromophenyl)(phenyl)methanamine is a synthetic intermediate widely utilized in organic synthesis. Its unique structure allows for the development of various pharmaceutical compounds, contributing to research in medicinal chemistry. This reagent plays a crucial role in the modification of molecular architectures, facilitating investigations into their biological activities and therapeutic potentials. -
Drug Impurity
Beclometasone dipropionate impurity 1, also known as Beclomethasone 21-acetate 17-propionate, serves as a drug impurity. It can be utilized in the analysis of Beclometasone dipropionate formulations, aiding in the assessment of purity and quality control processes. This compound is essential for researchers studying drug efficacy and safety profiles in pharmaceutical development. -
Drug Impurity
Pantoprazole Impurity 1 is a characterized impurity associated with the proton pump inhibitor Pantoprazole. Its presence in formulations can be crucial for quality control and regulatory compliance in pharmaceutical development. Researchers can utilize this impurity to study the stability, degradation pathways, and overall safety profiles of Pantoprazole and related compounds. This reagent aids in ensuring the integrity and efficacy of pharmaceutical products containing Pantoprazole. -
Drug Impurity
Paliperidone impurity 1 is a pharmaceutical impurity associated with Paliperidone, an atypical antipsychotic. It serves as a critical reference standard for the analysis, identification, and characterization of drug substances and formulations. This impurity is essential for ensuring the quality and compliance of pharmaceutical products within the analytical and regulatory environments of drug development. -
Drug Impurity
Brimonidine impurity 6 is a chemical entity that serves as an impurity in the pharmaceutical compound Brimonidine. It is primarily utilized in analytical chemistry for the characterization and quality control of Brimonidine formulations. This impurity can aid in understanding the structural integrity and stability of drug products, ensuring compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Salbutamol impurity 7 is a known impurity of the bronchodilator Salbutamol, which primarily targets beta-2 adrenergic receptors. This compound is important for analytical research and quality control in pharmaceutical development to ensure the purity and safety of Salbutamol formulations. Its presence can influence pharmacokinetics and therapeutic efficacy, making it relevant for studies focused on drug metabolism and impurities. -
Drug Impurity
Hydrocortisone impurity 5, also known as 6-Dehydrocortisol, is a known impurity of hydrocortisone. This compound is primarily used in the evaluation of drug purity and stability. Its presence can be critical for analytical methods in pharmaceutical research, ensuring the integrity of steroid formulations. Additionally, it serves as a reference standard in the development of quality control tests for hydrocortisone-based products. -
Drug Impurity
Quetiapine impurity 7 is an identified impurity of the atypical antipsychotic quetiapine, which acts primarily as a serotonin (5-HT) and dopamine (D2) receptor antagonist. This compound is essential for purity assessment in drug development and quality control processes, aiding in the identification and quantification of impurities in pharmaceutical formulations. Its study contributes to the understanding of quetiapine's overall safety and efficacy profile in clinical use. -
Drug Intermediate
3-Amino benzamidoxime, also known as 3-amino-N'-hydroxybenzene-1-carboximidamide, is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its chemical structure facilitates the formation of various active pharmaceutical ingredients, making it a valuable reagent in drug development. Researchers leverage this compound for its role in optimizing synthetic pathways and enhancing the yield of biologically active molecules. -
Drug Impurity
Lopinavir impurity 5 is a known impurity of the antiretroviral drug Lopinavir, primarily associated with the manufacturing process. As a chemical research reagent, it serves as a critical component for quality control and stability assessments in pharmaceutical formulations. Its identification and quantification are essential for ensuring the purity and efficacy of Lopinavir in therapeutic applications by supporting compliance with regulatory standards. -
Sunset Yellow FCF Impurity
Disodium 6,6′-oxybis(2-naphthalenesulfonate) is an impurity of Sunset Yellow FCF that functions primarily as a surfactant, emulsifier, and dispersant. This compound exhibits significant potential in enhancing the solubility and stability of formulations. It is utilized in the synthesis of polymers, pharmaceuticals, and agrochemicals, making it a valuable reagent for various chemical research applications. -
Drug Impurity
Tenofovir impurity 10 is a known impurity of the antiretroviral agent Tenofovir, primarily utilized in the study of drug formulations and quality control processes. This compound serves as a critical reference standard in pharmaceutical research, specifically for the detection and quantification of Tenofovir impurities during manufacturing. Its analysis plays an essential role in ensuring the safety and efficacy of Tenofovir-based therapies. -
Drug Impurity
Levothyroxine Impurity 5 is a counter ion impurity associated with Levothyroxine, primarily identified in the analytical characterization of this thyroid hormone. Its chemical profile is crucial for ensuring the quality and safety of Levothyroxine formulations in pharmaceutical research. This reagent can be utilized in stability studies, quality control, and method development to evaluate the purity of Levothyroxine and its formulations. -
Drug Impurity
Cabozantinib impurity 8 is a drug impurity related to the tyrosine kinase inhibitor cabozantinib, which primarily targets MET and VEGFR pathways. This compound serves as an important reference standard for analytical applications, particularly in the quality control and characterization of cabozantinib formulations. Its presence in pharmacological assessments aids in understanding the effects and safety profiles of cabozantinib derivatives in drug development. -
Voriconazole Impurity
10-Camphorsulfonic acid ethyl ester is recognized as a Voriconazole impurity. This compound serves as a valuable reference material for the analysis of Voriconazole in pharmaceutical research. It is utilized to study the synthesis pathways and to assess the purity of Voriconazole in various formulations. -
Drug Impurity
Haloperidol impurity 3, also known as 3-Ethyl haloperidol, is a synthetic impurity associated with the antipsychotic drug Haloperidol. This chemical can be used in method development and validation for pharmaceutical analysis and quality control. Its presence in drug formulations can impact biological activity and pharmacokinetics, making its study relevant for drug safety and efficacy assessments. -
Drug Intermediate
2-Methyl benzamideoxime is a synthetic intermediate primarily utilized in pharmaceutical synthesis. It serves as a versatile building block in the development of diverse drug compounds, facilitating modifications that enhance biological activity. Its application in the preparation of complex molecules makes it a valuable reagent in chemical research and drug development. -
Drug Impurity
Telmisartan impurity 17 is a known impurity associated with the angiotensin II receptor antagonist Telmisartan. This compound is important for analytical and quality control applications, as it aids in the assessment of drug purity and stability during formulation development. It serves as a critical reference standard in the evaluation of chromatographic techniques and contributes to the regulatory compliance of pharmaceutical products. -
Drug Impurity
Rivaroxaban impurity 18 is a drug impurity associated with Rivaroxaban, an anticoagulant that inhibits Factor Xa. This compound serves as an important reference for analytical methods in quality control and compliance testing of Rivaroxaban formulations. It is essential for researchers investigating the safety and efficacy profiles of anticoagulant therapies. -
Drug Impurity
Diclofenac impurity 1 is a known impurity of the nonsteroidal anti-inflammatory drug Diclofenac. It is utilized primarily in pharmaceutical research to assess the purity and quality of Diclofenac formulations. This compound serves as a reference material for analytical methods, including HPLC and mass spectrometry, enabling the identification and quantification of impurities in drug products. -
Drug Impurity
Quetiapine impurity 20 is a chemical impurity associated with the antipsychotic agent Quetiapine. It serves as an important reference standard for assessing the purity of pharmaceutical formulations containing Quetiapine. This reagent is essential for stability studies, quality control, and regulatory compliance in drug development and manufacturing processes. -
Drug Impurity
Hydrocortisone acetate impurity 1 is a chemical compound identified as an impurity of hydrocortisone acetate. This reagent is essential for quality control and analytical applications in pharmaceutical research, particularly in the development and assessment of corticosteroid formulations. Its presence must be monitored to ensure drug purity and efficacy, making it a critical component in the study of hydrocortisone acetate-based therapies. -
Drug Impurity
Cinacalcet impurity 10 is a known impurity of the drug Cinacalcet. This compound is significant for quality control and analytical purposes in pharmacological research. Its characterization is essential for ensuring the purity and compliance of Cinacalcet in various formulations, supporting studies on drug efficacy and safety. -
Drug Impurity
Rosuvastatin impurity 53 is a chemical impurity associated with Rosuvastatin, a statin used to lower cholesterol levels. Its characterization is essential for ensuring the purity and quality of Rosuvastatin formulations in pharmaceutical research and development. This impurity serves as a reference standard for analytical methods, enabling accurate detection and quantification in drug formulation analysis. -
Drug Impurity
Azilsartan impurity 1 is a known impurity of the antihypertensive drug Azilsartan, which primarily targets the angiotensin II receptor. This compound is used in research to assess the purity of Azilsartan formulations and to understand the drug’s stability and safety profile. Analysis of this impurity is crucial for regulatory compliance and quality control in pharmaceutical development. -
Drug Intermediate
GS-1427 intermediate-2 is a crucial chemical intermediate involved in the synthesis of GS-1427, a potent therapeutic agent. This compound serves as an essential building block in the development of novel pharmaceuticals, facilitating research into targeted therapies. Its role in the synthetic pathway underscores its importance in drug discovery and optimization processes. -
Drug Impurity
Ciprofloxacin impurity 6 is a known impurity associated with the antibiotic ciprofloxacin. It is primarily utilized in drug formulation and quality control to ensure the purity and safety of pharmaceutical products. This compound is important for assessing the stability and degradation pathways of ciprofloxacin and may serve as a reference standard in analytical methods. Researchers studying ciprofloxacin can leverage this impurity to better understand the compound's effects and potential interactions. -
Drug Impurity
Empagliflozin impurity 108 is a known impurity of the SGLT2 inhibitor Empagliflozin. This compound is utilized primarily in the evaluation of drug purity and stability in pharmaceutical development. Its identification and characterization are crucial for ensuring the quality and compliance of Empagliflozin formulations in research and regulatory settings. -
Ibuprofen Impurity
m-Isobutyl Ibuprofen is an impurity associated with the synthesis of Ibuprofen. This compound serves as a critical reference standard for analytical chemistry, particularly in the quality control of Ibuprofen formulations. Its biological activity may include modulation of COX enzyme pathways, making it relevant in pharmacokinetic studies and the evaluation of Ibuprofen's therapeutic profile. m-Isobutyl Ibuprofen is essential for researchers focusing on pharmaceutical development and impurity profiling. -
Amikacin Impurity
Amikacin impurity 2, also referred to as compound Impurity VI, is a recognized impurity associated with Amikacin. This compound is identified within Amikacin sulfate and is pertinent for studies focused on the characterization and quality control of antibiotic formulations. Research applications include assessing impurity profiles and evaluating the stability and efficacy of Amikacin-based therapies. -
Drug Impurity
Ketoprofen impurity 4 (rac-4’-Methyl ketoprofen) is a known impurity of the nonsteroidal anti-inflammatory drug Ketoprofen. This compound may be utilized in analytical chemistry and pharmaceutical research to assess purity and identify potential degradation products of Ketoprofen. Its presence and concentration can be critical for quality control and regulatory compliance in drug manufacturing processes. -
Drug Impurity
Methylprednisolone acetate impurity 3 is a recognized impurity of Methylprednisolone acetate, a corticosteroid used for its anti-inflammatory effects. This compound serves as a reference standard for analytical characterization and quality control in pharmaceutical research. It is essential for studying the stability, potency, and safety profiles of corticosteroid formulations. Its characterization can support the development and validation of analytical methods in the pharmaceutical industry. -
Drug Impurity
Ibrutinib Impurity 23 is a defined impurity associated with Ibrutinib, a Bruton's tyrosine kinase (BTK) inhibitor. This compound is vital for quality control and regulatory compliance in the development of Ibrutinib-based therapies. It serves as a reference standard for analytical chemistry applications, assisting researchers in ensuring the purity and consistency of pharmaceutical formulations containing Ibrutinib. -
Drug Impurity
Aceclofenac impurity 2, also known as Acetic aceclofenac, is a chemical impurity associated with the non-steroidal anti-inflammatory drug Aceclofenac. This compound is significant for quality control and regulatory compliance in pharmaceutical research. It is primarily utilized in pharmacokinetic studies and stability testing of Aceclofenac formulations. -
Drug Impurity
Pramipexole impurity 6, also known as Pramipexole N2-propionyl impurity, is a byproduct associated with the production of Pramipexole. This compound is utilized primarily in quality control and analytical research to assess the purity of Pramipexole formulations. Its detection and characterization are essential for ensuring compliance with regulatory standards in pharmaceutical development. -
Drug Intermediate
tBu-MTX-CO-NH-C2-O-C2-N3 is an azide compound that serves as a valuable drug intermediate for the synthesis of chemical inducers of dimerization. This compound facilitates the development of targeted therapeutics by enabling precise control over protein interactions. Its chemical structure allows for the incorporation of ligands such as Aurora A and Cereblon, making it suitable for a range of biological research applications, including studies focused on cell signaling and protein regulation. -
Drug Impurity
Aripiprazole impurity 21 is a detected impurity of Aripiprazole, an atypical antipsychotic drug that targets dopamine D2 and serotonin 5-HT1A receptors. This compound is relevant for analytical studies and method development in pharmacological research, ensuring the quality and purity of Aripiprazole formulations. Its characterization is essential for compliance with regulatory standards in drug development and manufacturing processes. -
Drug Impurity
Hydroxychloroquine impurity 1, also known as Hydroxychloroquine N-Oxide, is a chemical impurity associated with the pharmaceutical compound hydroxychloroquine. This impurity is of interest for its potential impact on drug efficacy and safety profiles in pharmacological studies. Researchers can utilize this compound to assess the quality and purity of hydroxychloroquine formulations within analytical chemistry and drug development applications. -
Drug Impurity
Fusidic acid impurity 6, also known as 9,11-Anhydro fusidic acid, is a chemical impurity associated with Fusidic acid. This compound serves as a valuable tool in pharmaceutical research, specifically for assessing the purity and stability of formulations containing Fusidic acid. Its profile is crucial for quality control and regulatory compliance in drug development processes. -
Drug Impurity
Pralatrexate impurity 1 is a specific chemical impurity associated with the antifolate drug Pralatrexate, which targets dihydrofolate reductase (DHFR). This compound is important for assessing the purity of Pralatrexate in drug formulation and quality control processes. Its characterization and analysis contribute to understanding the safety and efficacy of Pralatrexate-related therapies in cancer research and treatment. -
Drug Impurity
Rosuvastatin impurity 10 sodium is an impurity derived from Rosuvastatin sodium, commonly utilized in pharmaceutical research and quality control. This compound serves as a reference standard for assessing the purity of Rosuvastatin formulations, facilitating the development and validation of analytical methods. Its presence is critical for ensuring compliance with regulatory standards in drug development and formulation. -
Drug Impurity
Dabigatran impurity 47 is a chemical impurity associated with the anticoagulant drug Dabigatran. It serves as a critical reference standard for analytical testing and quality control in pharmaceutical research. The identification and quantification of this impurity are essential for ensuring the safety and efficacy of Dabigatran formulations in clinical applications. -
Cimetidine Impurity
2-Cyano-1,3-dimethylguanidine is a known impurity of Cimetidine, a histamine H2-receptor antagonist. This compound may be utilized in analytical studies to assess the purity and quality of pharmaceutical formulations containing Cimetidine. Its presence can provide insights into the synthesis and stability of related drug compounds in research applications. -
Drug Impurity
Ciprofloxacin impurity 2 hydrochloride is a drug impurity associated with Ciprofloxacin hydrochloride. It is primarily utilized in the characterization and quality control of Ciprofloxacin formulations. This compound supports research into the stability, efficacy, and safety profiles of ciprofloxacin-related pharmaceuticals, making it essential for analytical and regulatory assessments in pharmaceutical development.
